The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO WCGIC 2021 | Early colon and rectal cancer at ESMO WCGIC 2021
Deborah Mukherji, MBBS, FRCP, American University of Beirut Medical Center, Beirut, Lebanon discusses highlights for colorectal cancer presented during Session IX of the ESMO World Congress on Gastrointestinal Cancer 2021. Topics for discussion include research on combining chemotherapy, radiotherapy, and immunotherapy for the treatment of locally advanced rectal cancer in the neoadjuvant setting, controversial topics concerning rectal cancer management, women in oncology and adjuvant colon cancer treatment; results will be presented on manipulating the length of chemotherapy in adjuvant colon cancer treatment, and on using new circulating biomarkers to stratify patients and inform therapy intensity. This interview took place at the ESMO World Congress on Gastrointestinal Cancer 2021.
